Sign up for our eNewsletters
Get the latest news and updates

Industry News

Grand River Aseptic Manufacturing (GRAM)
GRAM and groninger teams complete successful FAT for the groninger filling line
A new high-volume filling line and GMP facility aim to support syringe and cartridge production with advanced isolator-based sterile processing.
April 15, 2026
Vetter Pharma International GmbH
©Vetter Pharma International GmbH: Vetter’s Des Plaines construction site is advancing on schedule (April 2026)
The capacity additions and facility upgrades aim to support early-stage manufacturing, aseptic processing, and supply of clinical trial materials.
April 15, 2026
Kincell Bio
Aerial view of Kincell Bio facility in Research Triangle Park, North Carolina
The CDMO added cleanrooms, quality control labs, and digital systems to support commercial-scale production, validation, and release of cell therapy products.
April 15, 2026
Regeneron
Regeneron logo on building
The collaboration integrates radiopharma manufacturing with antibody platforms to support scalable production and development of targeted oncology therapies.
April 14, 2026

Learning Resources

dreamstime_xxl_249858135
dreamstime_xxl_249858135
Sponsored
Global tariffs and trade tensions will continue to pressure biopharmaceutical manufacturers, driving supply chain decisions and the economics of domestic production. However, ...
March 25, 2026
gettyimages1337381197_1540x800
Sponsored
Learn how different temperature monitoring tools reveal what your pharmaceutical shipments experienced and how to choose the right one to protect your supply chain.
Feb. 12, 2026
dreamstime_xxl_249582173
dreamstime_xxl_249582173
Sponsored
Innovators are redefining bioreactor technology, cell and gene therapy manufacturing, pharmaceutical packaging, and small molecule APIs. Pharma Manufacturing’s 2025 Innovation...
Dec. 8, 2025
cover_gettyimages1320311776
cover_gettyimages1320311776
Sponsored
Faced with increasing quality, risk, and talent pressures, pharma manufacturers are embracing smart manufacturing and automation to overcome these challenges. Find out in this...
Nov. 20, 2025

Podcast

Editors' (re)View

editreview
Big Pharma and contract development and manufacturing organizations are making large capital expenditures to build infrastructure supporting the wildly popular medications.
March 6, 2026
editreview
Industrializing the manufacturing of these complex therapies is critical to ensure scalability and commercial viability, says the Alliance for Regenerative Medicine.
Feb. 6, 2026
editreview
The annual J.P. Morgan Healthcare Conference in San Francisco brought together executives who are positive about this year’s prospects for the sector.
Jan. 16, 2026
editreview
Large pharmaceutical companies have promised to invest more than $370 billion over the next five years in the U.S., driven by Trump’s threat of pharma-specific tariffs.
Dec. 19, 2025

Production

usflagcapitol
To counter the Chinese government’s investment, the U.S. must make a coordinated effort to grow biomanufacturing base, argues a bipartisan commission created by Congress.
Feb. 20, 2026
lillycorporatecentertmp190521988
The pharma giant has added to its inventory of orforglipron in anticipation of a favorable regulatory decision by the U.S. Food and Drug Administration.
Feb. 13, 2026
raleigh_skyline
Raleigh-Cary and Durham-Chapel Hill secured the first and third spots, respectively, as the nation’s most competitive markets for the production of therapeutic biologics.
Nov. 10, 2025
symphonxfinal
SymphonX, which runs all downstream unit operations in both fed-batch and continuous processes, will serve customers at Fujifilm’s Billingham manufacturing facility.
Nov. 6, 2025

Development

pillsonbelt_shutterstockfinal
These therapies are poised to reshape treatment standards this year, from next‑gen metabolic drugs to breakthrough advances in oncology, immunology, and rare diseases.
March 13, 2026
baselbridgeannaroth108_shutterstock
Home to pharma giants Roche and Novartis, the Swiss city along the Rhine River is attracting biotech companies of all sizes that are driving life sciences innovation.
March 3, 2026
aidrugdiscovery_shutterstock
As artificial intelligence tools proliferate, the real challenge is not generating ideas but turning them into chemically feasible and manufacturable paths.
Feb. 17, 2026
shutterstock_radiopharmafinal
Manufacturers face growing pressure to align drug design, production strategy, logistics, and workforce planning to ensure reliable, at-scale delivery.
Jan. 6, 2026

Information Technology

5514675881614805___practical_ai_gmp_asset_manageme
Sponsored
AI is helping life sciences manufacturers improve uptime, PM effectiveness, calibration planning, and reliability analysis. See where practical AI adds value in GMP asset management...
April 15, 2026
resilience2
Software platforms can seamlessly integrate with emerging technologies to unlock efficiencies, strengthen sustainability and enable proactive prevention of disruptions.
Sept. 10, 2025
shutterstock_1401286556
To prioritize data integrity in the lab, companies must implement good data practices throughout the R&D process
June 24, 2024
shutterstock_1970907203
Built-in ability to meet data integrity standards should be a central focus when selecting control systems and manufacturing execution systems for pharma manufacturing
May 2, 2024

Compliance

simtra_final
The agency cited the CDMO’s significant violations of current Good Manufacturing Practice regulations for finished pharmaceuticals at Simtra’s Halle/Westfalen facility.
March 16, 2026
novonordiskflags
The Danish drugmaker received a warning letter from the agency related to a Post-marketing Adverse Drug Experience inspection conducted last month.
March 11, 2026
fda_final
The agency issued a Complete Response Letter for Incyte’s supplemental Biologics License Application, citing inspection findings at Novo Nordisk’s fill-finish facility.
March 10, 2026
supremecourt
Despite the legal setback for President Trump’s country-specific tariffs, he retains the authority to impose Section 232 tariffs on pharmaceuticals imported to the U.S.
Feb. 20, 2026

Quality & Risk

shipping
Rising oil prices and disrupted shipping routes drove up costs, delaying sensitive shipments, and forcing pharmaceutical companies to rethink supply chain strategy.
April 8, 2026
trumprxfinal
Leerink Partners analysts see no near-term material changes to U.S. onshoring narrative, given Trump’s executive order late last week on pharmaceutical imports.
April 6, 2026
trumpeosign
Drug companies with Most Favored Nation pricing deals with the Trump administration are exempt, as are generic drugs, biosimilars, and related ingredients.
April 3, 2026
congress_shutterstock
Chinese production of active pharmaceutical ingredients and key starting materials is putting Americans at risk, according to a bipartisan congressional committee.
March 19, 2026